Fig. 2: The expression of NRF2 in the noncancerous mucosae, primary tumors, and metastatic lymph nodes. | Modern Pathology

Fig. 2: The expression of NRF2 in the noncancerous mucosae, primary tumors, and metastatic lymph nodes.

From: High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients

Fig. 2

A IHC staining for NRF2 in the noncancerous mucosae; (B) The difference of NRF2 positivity between tumors and noncancerous mucosae; (C) Representative IHC staining for NRF2/NQO1 in primary tumors and matched metastatic lymph nodes collected from two patients. P50: patient 50; P97: patient 97.

Back to article page